Once Versus Twice-Daily Oral Proton Pump Inhibitor Therapy for Prevention of Peptic Ulcer Rebleeding: A Propensity Score-Matched Analysis

BACKGROUND: After inpatient management of upper gastrointestinal bleeding (GIB) due to peptic ulcer disease (PUD), oral proton pump inhibitor (PPI) therapy is recommended at discharge to decrease rebleeding risk and improve ulcer healing. Our aim is to determine whether once-daily oral PPI dosing at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoub, Fares, Khullar, Vikas, Banerjee, Debdeep, Stoner, Patrick, Lambrou, Tiffany, Westerveld, Donevan R., Hanayneh, Wissam, Kamel, Amir Y., Estores, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997469/
https://www.ncbi.nlm.nih.gov/pubmed/29915630
http://dx.doi.org/10.14740/gr1011w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997469/
https://www.ncbi.nlm.nih.gov/pubmed/29915630
http://dx.doi.org/10.14740/gr1011w

Ejemplares similares